Lv12
70 积分 2024-11-01 加入
Efficacy and risk of donor-derived CAR-T treatment of relapsed B-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation
1小时前
已完结
Donor-derived CAR-T therapy improves the survival of relapsed B-ALL after allogeneic transplantation compared with donor lymphocyte infusion
1小时前
已完结
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
4小时前
已完结
Survival after stem-cell transplant in pediatric and young-adult patients with relapsed and refractory B-cell acute lymphoblastic leukemia
11小时前
已完结
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
20天前
已完结
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL
20天前
已完结
Tandem CD19/CD22 CAR T‐Cell Therapy as First‐Line Treatment for Adult Patients With High‐Risk Philadelphia Chromosome Negative B‐Cell Acute Lymphoblastic Leukemia
3个月前
已完结
Immunophenotype of CAR T-cells and associated apheresis products predicts clinical response in a single-center CD22 CAR T-cell therapy trial in B-cell acute lymphoblastic leukemia
3个月前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
3个月前
已完结
Using a Bigger Hammer: The Role of Stereotactic Body Radiotherapy in the Management of Oligometastases
3个月前
已关闭
皖公网安备34019202002308
